Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 2

1(14.3%)

7Total

N/A(6)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07458204Phase 2Not Yet Recruiting

Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer

Role: lead

NCT07242261Not ApplicableNot Yet Recruiting

Non-invasive Characterisation of Oral Carcinomas in Patients With Fanconi Anaemia

Role: lead

NCT06356363Not Yet Recruiting

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)

Role: lead

NCT05641012Unknown

Association Between Helioderma and Response to Immunotherapy in Patients With Metastatic Melanoma

Role: lead

NCT04408560Not ApplicableCompleted

Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer

Role: lead

NCT04108221Not ApplicableSuspended

Study Comparing Two Methods of TransversusAbdominis Plane

Role: lead

NCT02824016Not ApplicableCompleted

Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation

Role: lead

NCT03902964Completed

Needs Assessment After Cancer in Patients Treated for Breast Cancer

Role: lead

NCT02151214Not ApplicableCompleted

Efficacy of Parenteral Nutrition in Patients at the Palliative Phase of Cancer.

Role: collaborator

NCT02876731Not ApplicableCompleted

Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)

Role: lead

All 10 trials loaded